Das M, Musetti S, Huang L. RNA interference-based cancer drugs: the roadblocks, and the "delivery" of the promise. Nucleic Acid Ther. 2019 Apr;29(2):61-6. doi: 10.1089/nat.2018.0762
Gallego R, Codony-Servat J, Garcia-Albeniz X, Carcereny E, Longaron R, Oliveras A, Tosca M, Auge JM, Gascon P, Maurel J. Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer. Endocr Relat Cancer. 2009 Mar;16(1):311-7. doi: 10.1677/ERC-08-0250
Phanikumar CV, Maitra B. Valuing urban bus attributes: an experience in Kolkata. J Public Transport. 2006;9(2):69-87. doi: 10.5038/2375-0901.9.2.4
Phani Kumar CV, Basu D, Maitra B. Modeling generalized cost of travel for rural bus users: a case study. J Public Transport. 2004;7(2):59-72. doi: 10.5038/2375-0901.7.2.4
Michels KB, Rothman KJ. Update on unethical use of placebos in randomised trials. Bioethics. 2003 Apr;17(2):188-204.